Abstract:Purpose The aim of this study was to determine whether an interchromosomal effect (ICE) occurred in embryos obtained from reciprocal translocation (rcp) and Robertsonian translocation (RT) carriers who were following a preimplantation genetic diagnosis (PGD) with whole chromosome screening with an aCGH and SNP microarray. We also analyzed the chromosomal numerical abnormalities in embryos with aneuploidy in parental chromosomes that were not involved with a translocation and balanced in involved parental translocation chromosomes. Methods This retrospective study included 832 embryos obtained from rcp carriers and 382 embryos from RT carriers that were biopsied in 139 PGD cycles. The control group involved embryos obtained from age-matched patient karyotypes who were undergoing preimplantation genetic screening (PGS) with non-translocation, and 579 embryos were analyzed in the control group. A single blastomere at the cleavage stage or trophectoderm from a blastocyst was biopsied, and 24-chromosomal analysis with an aCGH/SNP microarray was conducted using the PGD/PGS protocols. Statistical analyses were implemented on the incidences of cumulative aneuploidy rates between the translocation carriers and the control group. Results Reliable results were obtained from 138 couples, among whom only one patient was a balanced rcp or RT translocation carrier, undergoing PGD testing in our center from January 2012 to June 2014. For day 3 embryos, the aneuploidy rates were 50.7% for rcp carriers and 49.1% for RT carriers, compared with the control group, with 44.8% at a maternal age < 36 years. When the maternal age was ≥ 36 years, the aneuploidy rates were increased to 61.1% for rcp carriers, 56.7% for RT carriers, and 60.3% for the control group. There were no significant differences. In day 5 embryos, the aneuploidy rates were 24.5% for rcp carriers and 34.9% for RT carriers, compared with the control group with 53.6% at a maternal age < 36 years. When the maternal age was ≥ 36 years, the aneuploidy rates were 10.7% for rcp carriers, 26.3% for RT carriers, and 57.1% for the control group. The cumulative aneuploidy rates of chromosome translocation carriers were significantly lower than the control group. No ICE was observed in cleavage and blastocyst stage embryos obtained from these carriers. Additionally, the risk of chromosomal numerical abnormalities was observed in each of the 23 pairs of autosomes or sex chromosomes from day 3 and day 5 embryos. Conclusion There was not enough evidence to prove that ICE was present in embryos derived from both rcp and RT translocation carriers, regardless of the maternal age. However, chromosomal numerical abnormalities were noticed in 23 pairs of autosomes and sex chromosomes in parental structurally normal chromosomes. Thus, 24-chromosomal analysis with an aCGH/SNP microarray PGD protocol is required to decrease the risks of failure to diagnose aneuploidy in structurally normal chromosomes.

Morphometric Analysis and Developmental Comparison of Embryos from Carriers with Balanced Chromosomal Rearrangements in Preimplantation Genetic Diagnosis Cycles.

Using SNP array to identify aneuploidy and segmental imbalance in translocation carriers.

Chromosomal Analysis of Blastocysts from Balanced Chromosomal Rearrangement Carriers

Chromosomal Analysis for Embryos from Balanced Chromosomal Rearrangement Carriers Using Next Generation Sequencing

Preimplantation development analysis of aneuploid embryos with different chromosomal abnormalities

Preliminary analysis of numerical chromosome abnormalities in reciprocal and Robertsonian translocation preimplantation genetic diagnosis cases with 24-chromosomal analysis with an aCGH/SNP microarray

Preimplantation genetic testing for complex chromosomal rearrangements: clinical outcomes and potential risk factors

The Correlation Between Morphological Parameters and the Incidence of De Novo Chromosomal Abnormalities in 3238 Biopsied Blastocysts.

[Analysis of Chromosomes of Embryos Derived from Translocation Carriers During Preimplantation Genetic Diagnosis Cycles].

The Establishment and Application of Preimplantation Genetic Haplotyping in Embryo Diagnosis for Reciprocal and Robertsonian Translocation Carriers

Identifying Balanced Chromosomal Translocations in Human Embryos by Oxford Nanopore Sequencing and Breakpoints Region Analysis

Chromosomal Concordance Between the Baby Produced by Preimplantation Genetic Testing Embryo and the Trophectoderm Biopsy: a Retrospective Study

Retrospective Analysis of Meiotic Segregation Pattern and Interchromosomal Effects in Blastocysts from Inversion Preimplantation Genetic Testing Cycles.

Preliminary Analysis of Relationship Between Morphology and Chromosome Abnormality in Human Preimplantation Embryos

Feasibility Study of Using Unbalanced Embryos As a Reference to Distinguish Euploid Carrier from Noncarrier Embryos by Single Nucleotide Polymorphism Array for Reciprocal Translocations.

Blastocyst Morphology Based on Uniform Time-Point Assessments is Correlated With Mosaic Levels in Embryos

Preimplantation genetic testing in couples with balanced chromosome rearrangement: a four-year period real world retrospective cohort study

Association of early cleavage, morula compaction and blastocysts ploidy of IVF embryos cultured in a time-lapse system and biopsied for genetic test for aneuploidy

Assessment of quadrivalent characteristics influencing chromosome segregation by analyzing human preimplantation embryos from reciprocal translocation carriers

Comparison of Chromosomal Status in Reserved Multiple Displacement Amplification Products of Embryos That Resulted in Miscarriages or Live Births: a Blinded, Nonselection Case–control Study

[Analysis of sex chromosome mosaicisms in early cleavage-stage human embryos and blastocysts with poor embryo quality scores].